 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: glycyl-glycyl-glycyl-L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide (4->9)-disulfide | Glypressin® | N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin | Terlivaz® | Variquel®
                                 terlipressin is an approved drug (UK (2001), FDA (2022)) Compound class: 
                                                            Peptide
                                 
                                    
                                        Comment: Terlipressin is a clinically used vasopressin analogue. Terlipressin is biotransformed to its active moiety, lysine vasopressin (LVP). It has vasoconstrictive, antihemorrhagic, and antidiuretic properties.
                                    
                                 | 
 | |||||||||||||||||
| Classification  | |
| Compound class | Peptide | 
| Approved drug? | Yes. UK MHRA (2001) | US FDA (2022) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 5114 | terlipressin | 
| Database Links  | |
| CAS Registry No. | 14636-12-5 (source: WHO INN record) | 
| ChEMBL Ligand | CHEMBL2135460 | 
| DrugBank Ligand | DB02638 | 
| DrugCentral Ligand | 2967 | 
| GtoPdb PubChem SID | 434122301 | 
| PubChem CID | 72081 | 
| Search Google for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N | 
| Search Google for chemicals with the same backbone | BENFXAYNYRLAIU | 
| Search PubMed clinical trials | terlipressin | 
| Search PubMed titles | terlipressin | 
| Search PubMed titles/abstracts | terlipressin | 
| UniChem Compound Search for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N |